LifeMD, Inc. Announces Cash Dividend for Series A Preferred Stock Holders
LifeMD, Inc. Announces Cash Dividend for Series A Preferred Stock Holders
The dividend will be paid on January 15, 2025, to holders of record at close of business on January 3, 2025.LifeMD authorized a cash dividend of $0.5546875 per share for its Series A Preferred Stock, payable January 15, 2025.
LifeMD授權每股現金分紅爲0.5546875美元，適用於其A系列優先股，支付日期爲2025年1月15日。
Quiver AI Summary
Quiver AI 概要
LifeMD, Inc. has announced a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock, which will be paid on January 15, 2025, to shareholders recorded by the end of January 3, 2025. LifeMD is a provider of virtual primary care services, offering telemedicine, lab and pharmacy access, and specialized treatments for over 200 conditions through a robust digital care platform and a large affiliated medical group. The announcement also includes cautionary notes about forward-looking statements, emphasizing that actual results may vary due to various risks and uncertainties.
LifeMD公司宣佈將向其8.875%系列A累積永久優先股的持有者支付每股0.5546875美元的現金分紅，該分紅將在2025年1月15日支付，支付對象爲截至2025年1月3日的股東。LifeMD是一家提供虛擬初級醫療服務的公司，利用強大的數字護理平台和大型附屬醫療集團，爲超過200種控制項提供遠程醫療、實驗室和藥房訪問以及專業治療。該公告還包含對前瞻性聲明的警示，強調實際結果可能因各種風險和不確定性而有所不同。
Potential Positives
潛在的積極因素
- The announcement of a cash dividend signals strong financial health and a commitment to returning value to shareholders.
- The dividend payment date and record date provide clear communication for investors, promoting trust and transparency.
- LifeMD's positioning as a leading provider of virtual primary care services may enhance investor confidence in its growth potential and sustainable business model.
- 現金分紅的公告標誌着強健的財務狀況以及對股東回報價值的承諾。
- 分紅支付日期和記錄日期爲投資者提供了清晰的溝通，促進了Trust和透明度。
- 作爲虛擬初級醫療服務的領先提供商，LifeMD的定位可能增強投資者對其增長潛力和可持續業務模式的信心。
Potential Negatives
潛在負面因素
- The announcement of a cash dividend may signal financial pressures or liquidity concerns, as companies typically only issue dividends when they have sufficient cash flow and profitability.
- The emphasis on forward-looking statements and associated risks may raise concerns among investors about the company's future performance and its ability to meet its projections, particularly given market uncertainties.
- The press release includes a cautionary note about risks and uncertainties that could materially affect actual results, which may create apprehension regarding the stability or growth prospects of the company.
- 現金分紅的公告可能表明財務壓力或流動性問題，因爲公司通常只有在擁有足夠的現金流和盈利能力時才會發放分紅。
- 對未來展望聲明及相關風險的強調可能會引發投資者對公司未來表現和達成預測能力的擔憂，尤其是考慮到市場的不確定性。
- 新聞稿中包含一條關於可能對實際結果產生重大影響的風險和不確定性的警告，這可能會引起對公司穩定性或增長前景的憂慮。
FAQ
常見問題
What is the dividend amount announced by LifeMD?
LifeMD公告的分紅金額是多少？
LifeMD has announced a cash dividend of $0.5546875 per share for its 8.875% Series A Preferred Stock.
LifeMD宣佈其8.875% A系列優先股的現金分紅爲每股0.5546875美元。
When will the dividend be paid by LifeMD?
LifeMD將於何時支付分紅？
The dividend will be paid on January 15, 2025, to holders of record at close of business on January 3, 2025.
分紅將於2025年1月15日支付，支付給在2025年1月3日營業結束時的登記持有人。
What services does LifeMD provide?
LifeMD提供什麼服務？
LifeMD provides virtual primary care, including telemedicine, laboratory access, pharmacy services, and specialized treatment for over 200 conditions.
LifeMD提供虛擬基礎醫療，包括遠程醫療、實驗室訪問、藥房服務以及針對200多種疾病的專門治療。
How can I learn more about LifeMD?
我如何能了解更多關於LifeMD的信息？
For more information about LifeMD and its offerings, visit their website at LifeMD.com.
欲了解更多關於LifeMD及其產品的信息，請訪問他們的網站LifeMD.com。
What should investors know about forward-looking statements?
投資者應該了解關於前瞻性聲明的哪些信息？
Forward-looking statements involve risks and uncertainties that may cause actual results to differ from current expectations. Refer to SEC filings for details.
前瞻性聲明涉及的風險和不確定性可能導致實際結果與當前預期有所不同。有關詳細信息，請參閱SEC文件。
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
免責聲明：這是由GlobeNewswire分發的新聞稿的人工智能生成摘要。用於總結這份稿件的模型可能會出錯。請在這裏查看完整發佈。
$LFMD Insider Trading Activity
$LFMD內部交易活動
$LFMD insiders have traded $LFMD stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
$LFMD的內部人士在過去6個月內在公開市場上交易了$LFMD股票2次。其中，有1次爲購買，1次爲出售。
Here's a breakdown of recent trading of $LFMD stock by insiders over the last 6 months:
以下是過去6個月內部人士對$LFMD股票的最新交易情況：
- JUSTIN SCHREIBER (Chief Executive Officer) sold 25,000 shares.
- STEFAN GALLUPPI (Chief Innovation Officer) purchased 3,000 shares.
- JUSTIN SCHREIBER（首席執行官）出售了25,000股。
- STEFAN GALLUPPI（首席創新官）購買了3,000股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟蹤內部交易，請查看Quiver Quantitative的內部交易儀表。
$LFMD Hedge Fund Activity
$LFMD對沖基金活動
We have seen 53 institutional investors add shares of $LFMD stock to their portfolio, and 72 decrease their positions in their most recent quarter.
我們看到53家機構投資者在最近的一個季度中增持了$LFMD股票，72家減少了其持倉。
Here are some of the largest recent moves:
以下是最近的一些重大變動：
- AQR CAPITAL MANAGEMENT LLC added 687,280 shares (+inf%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC added 664,329 shares (+719.5%) to their portfolio in Q3 2024
- EAM INVESTORS, LLC removed 411,610 shares (-100.0%) from their portfolio in Q2 2024
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 347,455 shares (-63.0%) from their portfolio in Q3 2024
- G2 INVESTMENT PARTNERS MANAGEMENT LLC removed 305,000 shares (-100.0%) from their portfolio in Q3 2024
- MORGAN STANLEY removed 287,843 shares (-45.9%) from their portfolio in Q3 2024
- LAURION CAPITAL MANAGEMENT LP removed 285,637 shares (-100.0%) from their portfolio in Q2 2024
- AQR CAPITAL MANAGEMENT LLC 在2024年第三季度增加了687,280股(+inf%)到他們的投資組合中
- MILLENNIUM MANAGEMENT LLC 在2024年第三季度增加了664,329股(+719.5%)到他們的投資組合中
- EAM INVESTORS, LLC 在2024年第二季度移除了411,610股(-100.0%)
- CUBIST SYSTEMATIC STRATEGIES, LLC 在2024年第三季度移除了347,455股(-63.0%)
- G2 INVESTMENT PARTNERS MANAGEMENT LLC 在2024年第三季度移除了305,000股(-100.0%)
- 摩根士丹利 在2024年第三季度移除了287,843股(-45.9%)
- LAURION CAPITAL MANAGEMENT LP 在2024年第二季度移除了285,637股(-100.0%)
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要跟蹤對沖基金的股票投資組合，請查看Quiver Quantitative的機構持有情況儀表。
Full Release
完整發佈
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) --
LifeMD, Inc.
(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
紐約，2024年12月24日（環球新聞通訊） --
LifeMD, Inc.
（納斯達克：LFMD），一家領先的虛擬初級醫療服務提供商，今天宣佈其董事會已授權向公司8.875%系列A累積永久優先股（納斯達克：LFMDP）的持有者支付現金分紅，每股爲0.5546875美元。
The preferred dividend will be paid on January 15, 2025, to holders of record at the close of business on January 3, 2025.
優先股息將於2025年1月15日支付給截至2025年1月3日營業結束時登記的持有人。
About LifeMD, Inc.
關於LifeMD公司。
LifeMD
is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit
LifeMD.com
.
LifeMD
是一家領先的虛擬初級醫療服務提供商。LifeMD提供遠程醫療、實驗室和藥房服務的獲取，以及針對超過200種疾病的專業治療，包括初級醫療、男性和女性健康、體重管理和激素治療。公司利用一個垂直整合的專有數字護理平台、一個覆蓋50個州的醫務組、一個22,500平方英尺的附屬藥房以及一個美國的患者護理中心，以增加對高質量和可負擔得起的護理的獲取。有關更多信息，請訪問
LifeMD.com
.
Cautionary Note Regarding Forward Looking Statements
關於前瞻性聲明的警示說明
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: "believe," "expect," "anticipate," "project," "should," "plan," "will," "may," "intend," "estimate," "predict," "continue," and "potential," or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: "believe," "expect," "anticipate," "project," "should," "plan," "will," "may," "intend," "estimate," "predict," "continue," and "potential," or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, "Risk Factors" identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, "Risk Factors" identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-k, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.
新聞稿中做出的任何前瞻性聲明均基於在發佈之日我們當前掌握的信息。我們無需承擔更新或修訂任何前瞻性聲明的義務，無論是由於新信息、未來事件或其他原因，除非適用法律或法規要求。
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
投資者聯繫
馬克·本尼森，財務長
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com
媒體聯繫
傑西卡·弗裏德曼，首席營銷官
press@lifemd.com
